Mice. All mice were injected with thromboplastin extracted from difco desiccated rabbit brain; to extract thromboplastin, this was mixed with normal saline and incubated in a water bath at a temperature of 470 C. The mixture was agitated briefly at 3-minute intervals, and after incubating for 10 minutes the extract was filtered through a pledget of cotton wool. The extract so made was then diluted further with normal saline and by trial on mice the concentration was adjusted so that a lethal dose was less than 0-2 ml. This was done to avoid killing animals by excessive increase of blood volume. As extracts prepared on different days from the same batch of desiccated rabbit brain were found to vary in strength when tested on the living animal, actual doses administered have not been stated here. Mice were injected into their tail veins.
In the first series, 28 mice that were given one lethal dose each died from fibrin embolism of the lungs. In the second series 112 mice received 2 to 12 injections in experiments lasting from1 to 44 days. These mice were generally injected at 3-to 4-day intervals, though on a few occasions a week elapsed between. On each injection day a small initial dose was used, the dose being increased by small amounts for each successive mouse injected until one was killed by thromboplastin extract. Mice were injected at random.
Others then received an amount slightly less than the fatal dose. Even so, occasional animals died from a dose that was not lethal to their fellows. This ensured that animals received high sublethal doses. Any mouse in which injection failed was killed. In 23 of this group organizing emboli were discovered in lung arteries.
Rabbits. All were injected with brain extract prepared from animals of the same stock as those used in this experiment. Thromboplastin extract was prepared in the same way as for the mice. Rabbits received repeated injections on a plan similar to that used for mice. Injections were generally given bi-weekly but on several occasions, as in mice, once a week. They received from 2 to 21 injections in experiments lasting from 7 to 93 days. Injections both in mice and rabbits were given rapidly.
The Preparation of Lung Sections in Mice and Rabbits. Asceptic precautions were observed in giving injections. This also applied to preparation of thromboplastin extract, though this substance, for obvious reasons, cannot itself be sterilized. Each animal was dissected immediately after death, and the lungs fixed in 4 per cent neutral formaldehyde solution. All lungs were distended with the solution during fixing to permit easier interpretation of changes in alveolar walls. In mice, heart and lungs were embedded in one piece, the microtome knife being carried through the whole coronally to include both lungs and both ventricles in the same section. In rabbits each of the lower lobes was divided into three portions.
Other lobes were embedded whole. All sections were stained with haematoxylin and eosin and Weigert's elastic tissue stain counterstained with van Gieson. Frozen sections were also made of the lungs and stained for fat with Sudan III.
PULMONARY LESIONS
Mice. Numerous unorganized fibrin masses were found in lung vessels and often in the right ventricle also in all but 5 mice dying immediately after an injection. In these 5 death was ascribed to anaphylaxis. Fibrin was not found in the left ventricle in a single mouse.
In only 23 mice out of the 112 in the second series were organizing emboli found: only 4 mice showed late stages of fibrin organization. Fig. 1 Arterial Elastic Tissue. In minute muscular arteries emboli sometimes stretched the internal elastic lamina to extreme thinness, though without rupture. At sites of organizing emboli damage to this membrane was evident in various ways, most commonly as rupture (Fig. 4) (Fig. 3 and 4) and some others medial scars sometimes containing distorted elastic fibrils.
(idema, usually adventitial, was infrequently noted (Fig. 4) . Though most pronounced in immediate proximity to lesions, it was also found away from emboli, sometimes as a curious lesion limited to the intima. In the adventitia, cedema took the form of a broad mantle containing inflammatory cells. No increase in adventitial collagen was encountered in any lesion.
Fat. Frozen sections of recent embolic lesions showed inconstant dusting of fine fat globules within fibrin masses, presumably derived from included plasma lipoid or from broken down entangled erythrocytes. Advanced lesions occasionally contained similar dusting with fat in deep parts of organizing emboli.
DISCUSSION
Three aspects of thrombo-embolic arteriosclerosis will be considered here: are thromboplastininduced arterial lesions solely ascribable to incorporation of fibrin into pulmonary vessels? do they resemble arteriosclerosis? and what evidence is there to support the concept of thrombo-embolic arteriosclerosis in man?
Pulmonary arterial lesions associated with repeated injections of thromboplastin extract cannot be attributed wholly to intimal incorporation of fibrin, because arteritis, segmental granulomatous destruction of arterial walls, and cedema are lesions characteristic of experimental anaphylaxis (Klinge, 1930; Vaubel, 1932; Goddard, 1947; and Hawn and Janeway, 1947) . However, inflammatory arteritis in rabbit lung is ascribed to anaphylaxis rather than to infected emboli, for the principal reason that similar lesions have not been encountered after injection of autogenous fibrin emboli prepared in vitro by chopping clot fine, using a safety razor blade. As it is not feasible to sterilize either thromboplastin extract or the emboli for fear of denaturing them, though risk of bacterial contamination of either substance is equally great, no inflammatory arteritis has been found when emboli prepared in vitro by the chopping technique were injected. That similar arteritic lesions in mouse lung, on the other hand, are anaphylactic is less certain because behaviour of fibrin emboli prepared in the way described for rabbits, has not been investigated in the lungs of mice (unpublished observations). Thromboplastin extract in repeated doses thus has only restricted usefulness in discovering how fibrin causes arterial disease, for it is impossible to obtain from autogenous sources thromboplastin extract sufficient for experiments like these and so escape errors liable to intrude when foreign protein is injected.
Nevertheless, though not numerous, other lesions like those of arteriosclerosis were also present ( Fig. 5 and 6 ). Such lesions are often illustrated in case reports of primary pulmonary arteriosclerosis. These experiments have shown, however, that sublethal doses of thromboplastin extract cause fibrin embolism of the lungs and that fibrin emboli become incorporated into arterial intima as connective tissue intimal thickenings sometimes containing new elastic fibres.
The evidence for thrombo-embolic pulmonary arteriosclerosis in man rests upon animal experiments, study of cor pulmonale associated with carcinomatous pulmonary embolism, and upon study of primary pulmonary arteriosclerosis associated with right ventricular hypertrophy.
The lesions of experimental thrombo-embolic arteriosclerosis using fibrin prepared in vitro correspond closely with those described and illustrated in human cases of primary pulmonary arteriosclerosis, a fact also commented upon by Harrison (1948) Ulrich, 1932-33; and Brenner, 1935) . It is for cases of this type that primary pulmonary hypertension is postulated as the counterpart of primary systemic hypertension with its attendant left ventricular enlargement.
Nevertheless, case reports indicate that not all examples of combined primary pulmonary vascular disease and right ventricular failure need be due to primary pulmonary hypertension. Chronic cor pulmonale associated with widespread organizing thrombosis of small intrapulmonary arteries, due to carcinomatous emboli mainly from gastric neoplasms, illustrates this (Krutzsch, 1920, and Saphir, 1947 )-an opinion reinforced by the case of Mantz and Craige (1951) in which right ventricular hypertrophy was associated with organization of small non-malignant embolic clots widely scattered in small intrapulmonary arterial branches. Remarkable also in descriptions of primary pulmonary arteriosclerosis is the large number of cases in which organizing clots in small pulmonary arteries are mentioned. These are uncritically regarded as thromboses secondary to arteriosclerosis, but arteriosclerosis secondary to the presence of blood clot is just as probable (Harrison, 1948 and Duguid, 1946 and Heard, 1947; Crawford and Levene, 1952; and Mehrotra, 1953) . Cases that could be explained as secondary to incorporation of small clots into pulmonary arterial intima are the second case of Goedel (1930) and the cases described by Eppinger and Wagner (1920) . Recurrent or chronic embolism with right ventricular failure due to large clots from veins below diaphragmatic level are now widely recognized (Carroll, 1950) . It is conceivable that there is a coagulative blood disorder in which fibrin separates out of systemic venous blood as small clots, instead of the large clots which are easier to find at autopsy.
Finally, even in normal people, circulating blood is not perhaps as fibrin free as is supposed. The comparatively rapid turnover of platelets, prothrombin, and fibrinogen suggests this. Other indirect evidence that blood might be coagulating continuously, derives from the work of Sternberger (1952) who claims to have recovered active thrombin from circulating blood by dissociating it from antithrombin. In disease on the other hand, the wide variety of conditions in which circulating fibrinolysin can be demonstrated also supports the view that intravascular coagulation is far commoner than general opinion at present holds (Biggs and MacFarlane, 1947, and Tagnon et al., 1946) .
There are thus substantial reasons to suggest that some cases of primary pulmonary arterio-
